Browse Category

COVID-19

301 INVESTIGATIONSChina Trade WarCOVID-19Defense Production ActExportImportInternational TradePPEU.S. Census Bureau

COVID-19’s Impact on 2020 Trade Flows

posted by Jennifer Diaz May 18, 2021 0 comments

COVID-19’S IMPACT ON 2020 TRADE FLOWS

Diaz Trade Law’s President, Jennifer Diaz,  and Associate Attorney, Sharath Patil, are enthusiastic to announce that our article, “COVID-19’S IMPACT ON 2020 TRADE FLOWS” was published by the Customs and International Trade Bar Association (CITBA) in its Spring 2021 newsletter. Below is the article for your reading pleasure.

Continue Reading

301 INVESTIGATIONSBest PracticesChinaChina Trade WarCOVID-19Customs ExpertEnforcementHTSImportInternational BusinessInternational TradeSpecial 301Trade PolicyU.S. Customs and Border Protection (CBP)U.S. Trade Representative (USTR)

301 Exclusion Extensions for COVID-19 Related Products

posted by Jennifer Diaz April 13, 2021 0 comments

On March 10, 2021, via Federal Register Notice ( 86 FR 13785), the United States Trade Representative (USTR) announced that 99 medical product exclusions will be extended from March 31, 2021, to September 30, 2021. This action extends a previous USTR action which extended these exclusions from December 31, 2020, to March 31, 2020 (85 FR 85831). Continue Reading

COVID-19ExportImportInternational TradeTrade PolicyU.S. Customs and Border Protection (CBP)U.S. Department of State (DOS)U.S. Food and Drug Administration (FDA)

Biden Administration Commits to Modernizing Regulatory Review

posted by Jennifer Diaz February 9, 2021 0 comments

Co-Authored by Sharath Patil

Background on Regulatory Review

U.S. federal laws come from a wide array of sources. They are generally organized under the following order of authority:  1) the U.S. constitution, 2) statutes passed by Congress, 3) treaties ratified by Congress, 4) case law, 5) executive orders, 6) regulations, and 7) agency guidance. After Congress has provided a federal agency with a policy mandate, an agency is empowered to promulgate regulations to provide detailed and binding rules on those matters.

Continue Reading

Best PracticesCOVID-19Customs ExpertEnforcementExportImportImport AlertInternational BusinessInternational LawInternational TradeMexicoSeizuresSupply ChainU.S. Customs and Border Protection (CBP)U.S. Food and Drug Administration (FDA)

FDA Import Alert on Mexican Hand Sanitizer

posted by Jennifer Diaz February 4, 2021 0 comments

For the first time in history, the United States Food and Drug Administration (FDA) has issued a countrywide import alert for any category of drug product. Specifically, on January 26, 2021, the FDA announced that it will Take Action to Place All Alcohol-Based Hand Sanitizers from Mexico on Import Alert to Help Prevent Entry of Violative and Potentially Dangerous Products into U.S., Protect U.S. Consumers. FDA singled out importations of hand sanitizers from Mexico due to the frequent use of methanol.

Continue Reading

301 INVESTIGATIONSCOVID-19Customs ExpertEnforcementExportImportInternational BusinessInternational LawInternational TradeInvestigationSpecial 301Supply ChainU.S. Customs and Border Protection (CBP)Vehicles

US Imposes Additional Tariffs on EU Goods

posted by Jennifer Diaz January 19, 2021 0 comments

On Wednesday, January 6, 2021, the Office of the United States Trade Representative (USTR), announced the revision of its Section 301 Action: Enforcement of U.S. WTO Rights in Large Civil Aircraft Dispute (86 FR 674).

 

Continue Reading

301 INVESTIGATIONSChinaChina Trade WarCOVID-19Customs BrokerCustoms ExpertEnforcementExportHTSImportInternational BusinessInternational LawInternational TradeInvestigationIPR, Trademarks and LogosSupply ChainU.S. Customs and Border Protection (CBP)

USTR Announces China 301 Tariff Exclusion Extensions for COVID-Related Products

posted by Jennifer Diaz December 30, 2020 1 Comment

On December 29, 2020, the Office of the United States Trade Representative (“USTR”) announced long-awaited extensions to a limited set of previously granted exclusions (for COVID-related products), that were set to expire on December 31, 2020. Meanwhile, importers across non-COVID industries are continuing to await guidance on their tariff exclusion extensions that are set to expire on December 31, 2020.

Continue Reading

Best PracticesCOVID-19CTPATCustoms ExpertEnforcementExportImportInternational BusinessInternational LawInternational TradeU.S. Customs and Border Protection (CBP)U.S. Food and Drug Administration (FDA)

DTL Tuned-In to the 2020 World Trade Center Miami’s International Trade Week – Check out our Recap:

posted by Jennifer Diaz May 27, 2020 0 comments

111During the weeklong series of 10 informative webinars on trade regulations, we heard TOP TIPs from numerous federal agencies, including U.S. Customs & Border Protection (CBP), U.S. Food and Drug Administration (FDA)’s Division of Southeast Imports, Miami’s CBP Fines, Penalties & Forfeitures (FP&F) Office, Miami CTPAT Field Office and more! Each webinar was produced to assist importers and exporters understand compliance and hot issues. Below are summaries of two webinars – FDA Import Operations Associated with COVID-19 Efforts and CTPAT – State of the Program / Minimum Security Criteria Updates:
Continue Reading

CBDChina Trade WarCOVID-19Customs ExpertEnforcementExportImportInternational LawInternational TradeSupply ChainU.S. Customs and Border Protection (CBP)U.S. Department of Homeland Security (DHS)

NEW EXECUTIVE ORDER: Federal Agencies Directed to Remove Regulatory Barriers

posted by Jennifer Diaz May 27, 2020 0 comments

Trump-Executive-Order-May-19-AP-2

In light of COVID-19, on May 19, 2020, the Trump Administration issued a new Executive Order (EO) entitled, “Regulatory Relief to Support Economic Recovery” directing all federal agencies to promote economic recovery through non-regulatory action. Importers, exporters, and other businesses under the jurisdiction of one of the 42 plus federal agencies that have pending federal enforcement actions should consider the regulatory reform mandated by the EO.

Continue Reading

ChinaCOVID-19U.S. Trade Representative (USTR)

Section 301 Tariff Updates: USTR Grants Exclusions & Seeks Comments on Products Necessary to Combat COVID-19!

posted by Jennifer Diaz April 17, 2020 0 comments

The Office of the United States Trade Representative (USTR), faced with the current COVID-19 pandemic, has moved quickly to grant numerous exclusion requests in March 2020; many of which are for medical supplies. USTR is also seeking comments from industry on whether products are necessary to combat COVID-19 spread and should be excluded from the additional duties. DTL has assisted clients in submitting comments to the USTR – this is the time to let your voice be heard.

Continue Reading

China Trade WarCustoms ExpertExportImportImport AlertInternational TradePPESupply ChainU.S. Customs and Border Protection (CBP)

PPE IMPORTS DURING COVID-19

posted by Jennifer Diaz April 16, 2020 0 comments

Diaz Trade Law’s President, Jennifer Diaz and Associate Attorney, Denise Calle are enthusiastic to announce that another one of their articles, “PPE Imports During COVID-19,” was published by Bloomberg Law! Below is the article reproduced with permission for your reading pleasure. We’d love to hear your feedback!

You can read the article here, by clicking PPE Imports Article (where you’ll have the ability to access all of the great hyperlinks) you cannot click on below.

Continue Reading